D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 753.10K 915.10K 842.10K 1.01M 1.17M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 848.30K 1.04M 960.30K 1.11M 1.27M
Operating Income -848.30K -1.04M -960.30K -1.11M -1.27M
Income Before Tax -8.36M 11.75M -3.05M -1.47M 23.42M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -8.36M 11.75M -3.05M -1.47M 23.42M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.36M 11.75M -3.05M -1.47M 23.42M
EBIT -848.30K -1.04M -960.30K -1.11M -1.27M
EBITDA -- -- -- -- --
EPS Basic -1.23 1.58 -0.44 -0.21 1.90
Normalized Basic EPS -0.50 -0.10 0.28 0.23 0.08
EPS Diluted -1.23 1.58 -0.44 -0.21 1.90
Normalized Diluted EPS -0.50 -0.10 0.28 0.23 0.08
Average Basic Shares Outstanding 6.80M 6.85M 6.96M 7.64M 7.87M
Average Diluted Shares Outstanding 6.80M 6.85M 6.96M 7.64M 7.87M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --